Top 5 "Recommendations" from ASCO

Options
mary625
mary625 Member Posts: 1,056
edited June 2014 in Clinical Trials, Research News, Podcasts, and Study Results


ASCO's New Top Five Choosing Wisely List.


Unbelievable.

· Share on FacebookShare on Twitter

Comments

  • SelenaWolf
    SelenaWolf Member Posts: 1,724
    edited October 2013

    Interesting, especially the recommendation against routine, follow-up PET/PET-CT...

    · Share on FacebookShare on Twitter
  • mary625
    mary625 Member Posts: 1,056
    edited October 2013


    I just feel this is very wrong, and it made me very angry. I feel that the patient should have some say in whether she'd prefer early detection of mets or not. I also think some patients would like to fight a lot harder than one chemo drug at a time against mets. All this "unnecessary radiation" from scanning--what about all the unnecessary radiation from mammograms that didn't find cancer? I believe it is wrong to lump all stages 0 through III in the same aftercare when a Stage III patient is facing up to a 50% chance of distant recurrence. We in Stage III need the scans! I won't even comment on the anti-nausea meds. And why do they call it a Top 5 list? Is this their top 5 priorities? The war against cancer is never going to be won this way.

    · Share on FacebookShare on Twitter
  • TectonicShift
    TectonicShift Member Posts: 752
    edited October 2014


    I'm with you, Mary.


    This article specifically talks about how in mouse models in the lab, Herceptin almost completely stopped very early bone mets but had negligible effect against well-established bone mets: http://www.cancerresearchuk.org/cancer-info/news/archive/cancernews/2013-02-26-Lab-research-suggests-Herceptin-could-benefit-more-women

    · Share on FacebookShare on Twitter
  • SelenaWolf
    SelenaWolf Member Posts: 1,724
    edited October 2013

    I assumed, from reading posts on the board, that routine, follow-up PET scans was something that was becoming more standard in cancer care in the States; not something that "the powers-that-be" wanted to cut back on...

    · Share on FacebookShare on Twitter
  • gpawelski
    gpawelski Member Posts: 564
    edited November 2013


    "Note: These test and treatment options should not be administered unless the physician and patient have carefully considered if their use is appropriate in the individual case. As an example, when a patient is enrolled in a clinical trial, these tests, treatments, and procedures may be part of the trial protocol and therefore deemed necessary for the patient’s participation in the trial.


    These items are provided solely for informational purposes and are not intended to replace a medical professional’s independent judgment or as a substitute for consultation with a medical professional. Patients with any specific questions about the items on this list or their individual situation should consult their health care provider. New evidence may emerge following the development of these items. ASCO is not responsible for any injury or damage arising out of or related to any use of these items or to any errors or omissions."


    I kind of think this can explain ASCO's thinking.

    · Share on FacebookShare on Twitter

Categories